Life Sciences Tools and Services
Company Overview of BIOCOM, Inc.
BIOCOM, Inc. is a life science association. The company focuses on initiatives that influence the region’s life science community in the development and delivery of products, as well as on capital formation, public policy, workforce development, group purchasing, and member services, such as networking events. It represents life sciences communities in Southern California. The company was founded in 1991 and is based in San Diego, California with an additional office in Los Angeles, California.
4510 Executive Drive
San Diego, CA 92121
Founded in 1991
Key Executives for BIOCOM, Inc.
Chief Executive Officer, President and Director
Vice President of Finance
Vice President and General Counsel
Chief Policy Officer and Senior Vice President
Chief Business Development Officer
Compensation as of Fiscal Year 2016.
BIOCOM, Inc. Key Developments
Biocom Appoints Julie Ames to the Position of Vice President of Corporate Communications
Mar 30 17
Biocom announced that Julie Ames has been appointment to the position of vice president of corporate communications. Ms. Ames will report directly to Biocom's president and CEO and will be responsible for instituting programs that effectively communicate the mission of the association. Prior to joining Biocom, Ms. Ames most recently served as president and founder of the Cambridge Group, where she engaged in solving communications, leadership and public policy problems for a range of organizations, including corporations, governments and non-profit organizations.
Biocom Appoints New Officers and Members to Board of Directors
Feb 27 17
Biocom announced the appointment of four new officers and four new members to its board of directors. These include the appointments of Dan Burgess to chairman, Christophe Schilling, Ph.D., to chair elect, Ted Schroeder to chair emeritus and Richard Pascoe to vice president, industry. Dan Burgess has overseen the discovery, preclinical development, clinical development and marketing of a number of pharmaceutical products. He first joined Biocom's board of directors in 2001, and he serves as chairman of the supervisory board of Nabriva Therapeutics, as chairman of the board of Atox Bio, as a board observer for Thesan Pharmaceuticals and as a board member of Arsanis, Inc., Cidara Therapeutics and Genoa Pharmaceuticals. Dr. Schilling, appointed as the board's chair elect, first became a director of Biocom's board in 2010. He is the founder and chief executive officer of Genomatica. The additional new members of the board are: Kelly Farrell, chief of staff and senior director 'oncology research & development, Pfizer. Kevin Tremblay, senior director, San Diego market leader, BioMed Realty. Ronnie Hanecak, Ph.D., senior director, licensing, UC Irvine Applied Innovation. Ho Sung Cho, Ph.D., vice president, biotherapeutics, Celgene.
Biocom Announces Promotion of Executives
Jan 31 17
Biocom announced the promotion of Jimmy Jackson to chief policy officer and of Rick Fultz to chief business development officer. These promotions reflect Biocom's recent growth in becoming a state-wide association, as the organization must expand its influence at the government and business levels accordingly. In Mr. Jackson's role as chief policy officer, he oversees Biocom's government affairs, policy development and policy-related programming, wherein he also directly manages Biocom'sSacramento portfolio. Mr. Jackson also concurrently serves as senior vice president of Biocom. In his nearly three decades of government experience within the San Diego and larger California regions, Mr. Jackson has established key, enduring relationships with many local and statewide policymakers. Prior to his role at Biocom, Mr. Jackson served as the chief of staff for now-retired California State Senator Dede Alpert, and he has served as staff to the California Legislature for a total of 14 years. As chief business development officer, Mr. Fultz leads Biocom's membership, sponsorship and fundraising efforts, growth and partnering initiatives and overall business development. Mr. Fultz concurrently serves as managing director of Biocom's purchasing group, and he is responsible for leading the internal purchasing group team, which is responsible for contract administration, member education and business development for the entirety of the purchasing group. Recently, Mr. Fultz has spearheaded successful partnerships with the County of Los Angeles, Advamed, the Craft Sourcing Collective and Thermo Fisher Scientific, and he is actively trailblazing for Biocom in the Bay Area and wherever Biocom's members reside.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|